Literature DB >> 6786275

Reversal of diabetes by allogenic islet transplantation without immunosuppression.

K M Bowen, K J Lafferty.   

Abstract

Streptozotocin-induced diabetes is temporarily reversed following the allo-transplantation of BALB/c (H-2d) islet tissue to normal CBA (H-2k) recipients, but by 2-4 week post-transplantation these animals return to their initial diabetic condition. Organ culture of allogeneic islet tissue in 95% O2 and 5% CO2 for 7 days prior to transplantation reduces the immunogenicity of the tissue, and cultured allografts give prolonged (greater than 110 days) reversal of diabetes in normal allogeneic recipients. The non-fasting blood sugar level remains in or very close to the normal range, urine glucose output is one to two orders of magnitude less than that of diabetic control animals and allografted animals regain their pre-morbid body weight within 60 days of transplantation. Surgical removal of the allograft results in a rapid return of the animal to the initial diabetic condition.

Entities:  

Mesh:

Year:  1980        PMID: 6786275     DOI: 10.1038/icb.1980.45

Source DB:  PubMed          Journal:  Aust J Exp Biol Med Sci        ISSN: 0004-945X


  13 in total

1.  The in-vitro inhibition of rat alloantigen presentation by immunotoxins--implications for allografting.

Authors:  K N Wiley; A Clark; M Fox
Journal:  Clin Exp Immunol       Date:  1989-04       Impact factor: 4.330

2.  Survival of deoxyguanosine-treated fetal thymus allografts is prevented by priming with dendritic cells.

Authors:  M T Benson; G Buckley; E J Jenkinson; J J Owen
Journal:  Immunology       Date:  1987-04       Impact factor: 7.397

3.  Experimental immuno-alteration.

Authors:  P E Lacy
Journal:  World J Surg       Date:  1984-04       Impact factor: 3.352

4.  Theory and practice of immunoregulation by tissue treatment prior to transplantation.

Authors:  K J Lafferty; S J Prowse
Journal:  World J Surg       Date:  1984-04       Impact factor: 3.352

5.  StrataGraft skin substitute is well-tolerated and is not acutely immunogenic in patients with traumatic wounds: results from a prospective, randomized, controlled dose escalation trial.

Authors:  John M Centanni; Joely A Straseski; April Wicks; Jacquelyn A Hank; Cathy A Rasmussen; Mary A Lokuta; Michael J Schurr; Kevin N Foster; Lee D Faucher; Daniel M Caruso; Allen R Comer; B Lynn Allen-Hoffmann
Journal:  Ann Surg       Date:  2011-04       Impact factor: 12.969

6.  Prevention of rejection of murine islet allografts by pretreatment with anti-dendritic cell antibody.

Authors:  D L Faustman; R M Steinman; H M Gebel; V Hauptfeld; J M Davie; P E Lacy
Journal:  Proc Natl Acad Sci U S A       Date:  1984-06       Impact factor: 11.205

7.  Dendritic cells in islets of Langerhans constitutively present beta cell-derived peptides bound to their class II MHC molecules.

Authors:  Boris Calderon; Anish Suri; Mark J Miller; Emil R Unanue
Journal:  Proc Natl Acad Sci U S A       Date:  2008-04-21       Impact factor: 11.205

8.  Nonenzymatic isolation and culture of adult islets from atrophic pancreata of copper-deficient rats: a morphologic analysis.

Authors:  C Weaver; R L Sorenson; B Kobienia
Journal:  In Vitro Cell Dev Biol       Date:  1988-02

9.  Evidence for major histocompatibility complex restriction in transplantation immunity.

Authors:  W K Silvers; H L Fleming; A Naji; C F Barker
Journal:  Proc Natl Acad Sci U S A       Date:  1982-01       Impact factor: 11.205

10.  Low-temperature culture of human islets or in vivo treatment with L3T4 antibody produces a marked prolongation of islet human-to-mouse xenograft survival.

Authors:  C Ricordi; P E Lacy; K Sterbenz; J M Davie
Journal:  Proc Natl Acad Sci U S A       Date:  1987-11       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.